Background
Dose-response-time data analysis Dose-response-time (DRT) data analysis acts as a substitute to traditional PK/PD-modelling when pharmacokinetic data are sparse or absent. This is typically the case for locally administered drugs (e.g. ophthalmics) or when the pharmacological response precedes the plasma exposure (e.g. pulmonary administration). The technique is based on the assumption that the pharmacological response is driven by the presence of the drug in an intermediate biophase compartment.
Aim of this study
The present study was performed to demonstrate the utility of DRT data analysis. In order to do so, a large preclinical biomarker dataset on the interaction between nicotinic acid (NiAc) and free fatty acids (FFA) were analysed. Data were collected from studies that examined different rates, routes, and modes of NiAc provocations on the FFA time course. All exposure data of NiAc were intentionally excluded in this study.
Materials and Methods
Depending on the route of administration, the input is either directly into the biophase (intravenous administration) or absorbed into the biophase from the gut (oral administration). The biophase model structures were evolved through a series of steps were data of different routes and rates sequentially were included and the model complexity increased. Step Model Description Experimental data
First-order output IV + PO
Final biophase structure Intravenous dose
where A b , k, and Inf are the drug amount, the elimination rate constant, and the intravenous infusion regime respectively. Oral dose
where D, A g , V max,g , and K m,g are the drug dose, the gut drug amount, the maximal absorption rate, and the Michaelis constant.
Pharmacodynamic model
Turnover of FFA is described by
where k in , k out , R 0 , p, and M i , i = 1, . . . , 8 are the rate of production, the fractional turnover rate, the baseline of response, the amplification factor, and the moderators respectively and
where I max , ID 50 , and γ are the drug efficacy, drug potency, and Hill exponent respectively. The moderators M 1 , . . . M 8 are described by
with
where K i is the integral gain parameter.
Results
The model was successfully fitted on a population and individual level for all NEFA time courses. 
Half-lives for the three rate constants k out , k tol , and K i with 90% bootstrap prediction intervals. 
Conclusions
Inhibitory Imax-model, driven by the biophase amount, controls turnover of FFA.
Second generation NiAc/FFA model used encompassing integral control (slow) and moderator (rapid and oscillatory) feedback.
Model successfully fitted to all time courses in normal rats.
Dose-response-time data analysis can model non-linearities in the biophase.
Slow integral control feedback allows 90% adaptation within 10 days.
Half-life of the slow integral control feedback ranged between 3-12 hrs.
New numerically algorithms, more efficient than conventional software like e.g. NONMEM, were successfully applied in the mixed-effect approach.
